Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Microfluidic chip technology integrates basic operational units such as sample preparation, reaction, analysis, and detection, harnessing techniques from the fields of chemistry and biology into a chip of several square centimeters, automatically completing the entire analysis process.

Imagine being a pediatric kidney transplant patient and having to miss school or extracurricular activities because of clinic appointments and routine blood tests. Now imagine being offered a take-home kit that has everything you and your ca

Biocartis announced it has entered into an agreement with AstraZeneca. The goal of the agreement will be to obtain faster lung cancer molecular diagnostic biomarker results in Europe. A prospective lung cancer study with the Idylla EGFR Mut

Becton Dickinson said today that the US Food and Drug Administration has granted 510(k) clearance for its BD Max enteric viral panel, a molecular diagnostic test for the detection and differentiation of pathogens that cause viral gastroenter

Siemens Healthineers (Erlangen, Germany) has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marki

December 22nd 2018 was Winter Solstice. Ancient Chinese believed that Yangqi (positive or muscular things) will become stronger and stronger after this day and a new life cycle begins, so it should be celebrated as an auspicious day. It was

Sysmex and MolecularMD have signed a non-exclusive collaboration agreement focused on the development and commercialization of companion diagnostics for precision medicine. As part of the collaboration, the firms said they will integrate the

Greiner Bio One International (Kremsmnster, Obersterreich, Austria) has launched the innovative VACUETTE SAFELINK tube holder with male luer lock that facilitates quick and easy blood collection. The tube offers simple handling and can be us

The global point of care (POC) urinalysis market is projected to grow at a CAGR of more than 3% over the 2018-2022 period, driven mainly by the rising prevalence of nephropathic disorders and urinary tract infections (UTIs) which is generati

Danaher today initiated its earning outlook for 2019, saying EPS is anticipated to be in the range of $4.02 to $4.12. On a non-GAAP basis, EPS is expected to be in the range of $4.75 to $4.85, which assumes non-GAAP core revenue growth of ab

The New York State Department of Health has approved a whole-genome and transcriptome sequencing oncology test developed by the New York Genome Center for clinical testing. According to NYGC, it is the first whole-genome cancer test to rece